1 Bluebird Bio Inc Receivables Turnover Ratio (BLUE), from the first quarter 2025 to the first quarter 2024 current and historic results, rankings and more - CSIMarket

Company Name, Ticker, Industry, else..

Growth Rates

Profitability

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

• Sales per Employee

• Income per Employee

• Inventory Turnover

• Asset Turnover

• Receivables Turnover

Dividend Comparisons

Bluebird Bio Inc (NASDAQ: BLUE)

Sector • Healthcare Industry • Biotechnology & Pharmaceuticals

Industry • Biotechnology & Pharmaceuticals

Sector • Healthcare

Bluebird Bio Inc Accounts Receivables Turnover Ratio from the first quarter 2025 to the first quarter 2024

Quarterly Results, Trends, Rankings, Statistics

According to Bluebird Bio Inc Balance Sheet, in the first quarter 2025, company has not reported any Accounts receivable.
See Bluebird Bio Inc Balance Sheet

If we take a look into Healthcare sector 412 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2025 from 0 to 2748.

What is Receivable Turnover Ratio?
What is Bluebird Bio Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BLUE Receivables Turnover Ratio	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Receivable Change	-	-	-	-	-
Y / Y Revenue Change	108.43 %	391.72 %	-14.36 %	133.69 %	680.05 %
Receivable Turnover Ratio (TTM)	-	-	-	9.55	7.95
BLUE's Total Ranking	# 2748	# 0	# 2726	# 2642	# 2829
Accounts Receivable average collection period days	-	-	-	38	46
Seq. Receivable Change	-	-	-	-	-
Seq. Revenue Change	0.5 %	262.99 %	-34.09 %	-13.31 %	137.08 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 34
Healthcare Sector	# 413
Overall Market	# 2748

Receivable Turnover Ratio Statistics
High	Average	Low
0.24	0.04	-0.06
(Mar 31 2025)		(Sep 30 2022)

BLUE Company Profile • Back to BLUE Efficiency Comparisons • Compare BLUE Receivables Turnover Ratio to its Competitors

Financial Statements
Bluebird Bio Inc 's Accounts Receivable	$ 0 Millions	Visit BLUE's Balance sheet
Bluebird Bio Inc 's Sales TTM	$ 104 Millions	Visit BLUE's Income Statement
Sources of BLUE's Revenues		Visit BLUE's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
BLUE's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
BLUE's Growth Rates	BLUE's Roa	BLUE's Inventory Turnover Ratio	BLUE's Dividend Comparisons
BLUE's Profitability Ratios	BLUE's Roi	BLUE's Asset Turnover Ratio	BLUE's Dividend Growth
BLUE's Valuation Ratios	BLUE's Roe	BLUE's Financial Strength Ratios	BLUE's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector

Receivable Turnover Ratio

Revenues for 12 Months ending Mar 31 2025

Receivable at quarter ending Mar 31 2025

Date modified: 2026-08-29T17:19:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.